James T Rosenbaum1,2,3, Mark J Asquith4. 1. Casey Eye Institute, Oregon Health & Science University, Portland, OR, 97239, USA. rosenbaj@ohsu.edu. 2. Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA. rosenbaj@ohsu.edu. 3. Legacy Devers Eye Institute, 1040 NW 22nd Ave, Suite 200, Portland, OR, 97210, USA. rosenbaj@ohsu.edu. 4. Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA.
Abstract
PURPOSE OF REVIEW: The microbiome is the term that describes the microbial ecosystem that cohabits an organism such as humans. The microbiome has been implicated in a long list of immune-mediated diseases which include rheumatoid arthritis, ankylosing spondylitis, and even gout. The mechanisms to account for this effect are multiple. The clinical implications from observations on the microbiome and disease are broad. RECENT FINDINGS: A growing number of microbiota constituents such as Prevotella copri, Porphyromonas gingivalis, and Collinsella have been correlated or causally related to rheumatic disease. The microbiome has a marked effect on the immune system. Our understanding of immune pathways modulated by the microbiota such as the induction of T helper 17 (Th17) cells and secretory immunoglobulin A (IgA) responses to segmented filamentous bacteria continues to expand. In addition to the gut microbiome, bacterial communities of other sites such as the mouth, lung, and skin have also been associated with the pathogenesis of rheumatic diseases. Strategies to alter the microbiome or to alter the immune activation from the microbiome might play a role in the future therapy for rheumatic diseases.
PURPOSE OF REVIEW: The microbiome is the term that describes the microbial ecosystem that cohabits an organism such as humans. The microbiome has been implicated in a long list of immune-mediated diseases which include rheumatoid arthritis, ankylosing spondylitis, and even gout. The mechanisms to account for this effect are multiple. The clinical implications from observations on the microbiome and disease are broad. RECENT FINDINGS: A growing number of microbiota constituents such as Prevotella copri, Porphyromonas gingivalis, and Collinsella have been correlated or causally related to rheumatic disease. The microbiome has a marked effect on the immune system. Our understanding of immune pathways modulated by the microbiota such as the induction of T helper 17 (Th17) cells and secretory immunoglobulin A (IgA) responses to segmented filamentous bacteria continues to expand. In addition to the gut microbiome, bacterial communities of other sites such as the mouth, lung, and skin have also been associated with the pathogenesis of rheumatic diseases. Strategies to alter the microbiome or to alter the immune activation from the microbiome might play a role in the future therapy for rheumatic diseases.
Authors: Jens T Van Praet; Erin Donovan; Inge Vanassche; Michael B Drennan; Fien Windels; Amélie Dendooven; Liesbeth Allais; Claude A Cuvelier; Fons van de Loo; Paula S Norris; Andrey A Kruglov; Sergei A Nedospasov; Sylvie Rabot; Raul Tito; Jeroen Raes; Valerie Gaboriau-Routhiau; Nadine Cerf-Bensussan; Tom Van de Wiele; Gérard Eberl; Carl F Ware; Dirk Elewaut Journal: EMBO J Date: 2015-01-19 Impact factor: 11.598
Authors: Ana Gutiérrez; Pedro Zapater; Oriol Juanola; Laura Sempere; Marifé García; Raquel Laveda; Antonio Martínez; Michael Scharl; José M González-Navajas; José Such; Reiner Wiest; Gerhard Rogler; Rubén Francés Journal: Am J Gastroenterol Date: 2016-02-23 Impact factor: 10.864
Authors: Mary-Ellen Costello; Francesco Ciccia; Dana Willner; Nicole Warrington; Philip C Robinson; Brooke Gardiner; Mhairi Marshall; Tony J Kenna; Giovanni Triolo; Matthew A Brown Journal: Arthritis Rheumatol Date: 2015-03 Impact factor: 10.995
Authors: Tomohisa Sujino; Mariya London; David P Hoytema van Konijnenburg; Tomiko Rendon; Thorsten Buch; Hernandez M Silva; Juan J Lafaille; Bernardo S Reis; Daniel Mucida Journal: Science Date: 2016-06-02 Impact factor: 47.728
Authors: Julie Teresa Marchesan; Elizabeth Ann Gerow; Riley Schaff; Andrei Dan Taut; Seung-Yun Shin; James Sugai; David Brand; Aaron Burberry; Julie Jorns; Steven Karl Lundy; Gabriel Nuñez; David A Fox; William V Giannobile Journal: Arthritis Res Ther Date: 2013-11-12 Impact factor: 5.156
Authors: Michelle I Smith; Tanya Yatsunenko; Mark J Manary; Indi Trehan; Rajhab Mkakosya; Jiye Cheng; Andrew L Kau; Stephen S Rich; Patrick Concannon; Josyf C Mychaleckyj; Jie Liu; Eric Houpt; Jia V Li; Elaine Holmes; Jeremy Nicholson; Dan Knights; Luke K Ursell; Rob Knight; Jeffrey I Gordon Journal: Science Date: 2013-01-30 Impact factor: 47.728